CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-20
DOI
10.1186/s12935-020-01605-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
- (2020) Zachary T. Freeman et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapy in gastrointestinal cancer: the current scenario and future perspectives
- (2020) Mohammed Abdul-Latif et al. CANCER TREATMENT REVIEWS
- Exosomal miRNAs in tumor microenvironment
- (2020) Shiming Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
- (2020) Helen Kotanides et al. MOLECULAR CANCER THERAPEUTICS
- CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases
- (2020) Hiu Yi Wong et al. JOURNAL OF AUTOIMMUNITY
- Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
- (2020) Byung Woog Kang et al. ESMO Open
- Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex-vivo targeting immune checkpoint molecules
- (2019) Guoying Zhou et al. JOURNAL OF HEPATOLOGY
- IL-17 inhibits CXCL9/10-mediated recruitment of CD8+ cytotoxic T cells and regulatory T cells to colorectal tumors
- (2019) Ju Chen et al. Journal for ImmunoTherapy of Cancer
- Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes
- (2019) James O. Jones et al. CANCER TREATMENT REVIEWS
- 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and other Intracranial Cancers
- (2019) Karolina I. Woroniecka et al. CLINICAL CANCER RESEARCH
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Immunotherapy in advanced gastric cancer, is it the future?
- (2018) C. Coutzac et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
- (2018) Juan M. Zapata et al. Frontiers in Immunology
- Molecular classification of gastric cancer
- (2017) Christoph Röcken EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
- (2016) Alfonso R. Sanchez-Paulete et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Molecular targeted therapy for the treatment of gastric cancer
- (2016) Wenting Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells
- (2014) G. Hodge et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo
- (2014) L. Sabbagh et al. JOURNAL OF IMMUNOLOGY
- CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion
- (2013) Marie-Clare St. Rose et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeting peripheral blood pro-inflammatory CD28null T cells and natural killer T-like cells by inhibiting CD137 expression: Possible relevance to treatment of bronchiolitis obliterans syndrome
- (2013) Greg Hodge et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells
- (2013) Laurent Sabbagh et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Opposing Roles for TRAF1 in the AlternativeversusClassical NF-κB Pathway in T Cells
- (2012) Ann J. McPherson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses
- (2011) Shannon E. Smith et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
- (2010) Juan Dubrot et al. INTERNATIONAL JOURNAL OF CANCER
- Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma
- (2010) Guoqiang Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tissue-specific expression of TIPE2 provides insights into its function
- (2010) Guizhong Zhang et al. MOLECULAR IMMUNOLOGY
- The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling
- (2008) Jihyun Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now